TUMEDEI, MARIA MADDALENA
TUMEDEI, MARIA MADDALENA
DIPARTIMENTO DI SCIENZE BIOMEDICHE E NEUROMOTORIE
Dottorandi
Comparative Evaluation of Commercial, Freely Available, and Open-Source Tools for Single-Cell Analysis Within Freehand-Defined Histological Brightfield Image Regions of Interest
2025 Piccinini, Filippo; Tazzari, Marcella; Tumedei, MARIA MADDALENA; Normanno, Nicola; Castellani, Gastone; Carbonaro, Antonella
Data Science for Health Image Alignment: A User-Friendly Open-Source ImageJ/Fiji Plugin for Aligning Multimodality/Immunohistochemistry/Immunofluorescence 2D Microscopy Images
2024 Piccinini, Filippo; Tazzari, Marcella; Tumedei, Maria Maddalena; Stellato, Mariachiara; Remondini, Daniel; Giampieri, Enrico; Martinelli, Giovanni; Castellani, Gastone; Carbonaro, Antonella
HDAC6 as a Prognostic Factor and Druggable Target in HER2-Positive Breast Cancer
2024 Cortesi, M.; Bravaccini, S.; Ravaioli, S.; Petracci, E.; Angeli, D.; Tumedei, M. M.; Balzi, W.; Pirini, F.; Zanoni, M.; Possanzini, P.; Rocca, A.; Palleschi, M.; Ulivi, P.; Martinelli, G.; Maltoni, R.
Deep Learning-Based Tool For Morphotypic Analysis Of 3D Multicellular Spheroids
2023 Piccinini F.; Peirsman A.; Stellato M.; Pyun J.C.; Tumedei M.M.; Tazzari M.; De Wever O.; Tesei A.; Martinelli G.; Castellani G.
Why the complications of COVID-19 patients differ in elderly and young cancer patients
2022 Bravaccini, Sara; Nicolini, Fabio; Zanoni, Michele; Gaimari, Anna; Cerchione, Claudio; Maltoni, Roberta; Pirini, Francesca; Mazzotti, Lucia; Cortesi, Michela; Ravaioli, Sara; Tumedei, Maria Maddalena; Mazza, Massimiliano
The Interplay Between Programmed Death Ligand 1 and Vimentin in Advanced Non-Small-Cell Lung Cancer
2021 Bronte, Giuseppe; Puccetti, Maurizio; Petracci, Elisabetta; Landi, Lorenza; Cravero, Paola; Scodes, Simona; Ulivi, Paola; Ravaioli, Sara; Tumedei, Maria Maddalena; Burgio, Marco Angelo; Cappuzzo, Federico; Delmonte, Angelo; Crinò, Lucio; Bravaccini, Sara
Are BMI and Negative Hormone Receptors Prognostic Factors in HER2+ Early-stage Breast Cancer?
2020 Maltoni R.; Palleschi M.; Altini M.; Massa I.; Balzi W.; Ravaioli S.; Tumedei M.M.; Rocca A.; Bravaccini S.
Are we ready to use TMB in breast cancer clinical practice?
2020 Ravaioli S.; Limarzi F.; Tumedei M.M.; Palleschi M.; Maltoni R.; Bravaccini S.
Atezolizumab plus Nab-paclitaxel in PD-L1–Positive TNBC—Letter
2020 Bravaccini S.; Ravaioli S.; Tumedei M.M.; Rocca A.; Palleschi M.; Puccetti M.; Parrella P.; Altini M.; Maltoni R.
Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast Cancer
2020 Maltoni R.; Palleschi M.; Ravaioli S.; Tumedei M.M.; Rocca A.; Melegari E.; Altini M.; Puccetti M.; Manunta S.; Bravaccini S.
Impressive clinical response to anti-PD-1 therapy in epithelioid mesothelioma with high clonal PD-L1 expression and EML4-ALK rearrangement
2020 Bronte, Giuseppe; Delmonte, Angelo; Burgio, Marco Angelo; Verlicchi, Alberto; Puccetti, Maurizio; Bravaccini, Sara; Cravero, Paola; Tumedei, Maria Maddalena; Diano, Danila; Rossi, Giulio; Ulivi, Paola; Martinelli, Giovanni; Crinò, Lucio
Ki67 and PR in patients treated with CDK4/6 Inhibitors: A real-world experience
2020 Palleschi M.; Maltoni R.; Ravaioli S.; Vagheggini A.; Mannozzi F.; Fanini F.; Pirini F.; Tumedei M.M.; Barzotti E.; Cecconetto L.; Sarti S.; Manunta S.; Possanzini P.; Fedeli A.; Curcio A.; Altini M.; de Giorgi U.; Rocca A.; Bravaccini S.
Tumor-Infiltrating Lymphocytes (TILs) and Risk of a Second Breast Event After a Ductal Carcinoma in situ
2020 Farolfi A.; Petracci E.; Serra L.; Ravaioli A.; Bravaccini S.; Ravaioli S.; Tumedei M.M.; Ulivi P.; Canale M.; Puccetti M.; Falcini F.; Folli S.; Curcio A.; Rocca A.
Are there differences in androgen receptor expression in invasive breast cancer in African (Tanzanian) population in comparison with the Caucasian (Italian) population?
2018 Bravaccini S.; Ravaioli S.; Amadori D.; Scarpi E.; Puccetti M.; Rocca A.; Tumedei M.M.; Masalu N.; Kahima J.; Pangan A.; Faustine L.; Farolfi A.; Maltoni R.; Bonafe M.; Serra P.; Bronte G.